-
1
-
-
0016271462
-
Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases
-
Spiro RH, Huvos AG, and Strong EW (1974). Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases. Am J Surg 128, 512-520.
-
(1974)
Am J Surg
, vol.128
, pp. 512-520
-
-
Spiro, R.H.1
Huvos, A.G.2
Strong, E.W.3
-
2
-
-
77956829338
-
Salivary gland diseases
-
Clinical Pathology Correlations. JA Regezi, JJ Sciubba, and RCK Jordan (Eds). Saunders, St Louis, MO
-
Carlson ER, Kim J, Mirowski GW, Stewart JCB, and Zarbo RJ (2008). Salivary gland diseases. In Oral Pathology: Clinical Pathology Correlations. JA Regezi, JJ Sciubba, and RCK Jordan (Eds). Saunders, St Louis, MO. pp. 179-215.
-
(2008)
Oral Pathology
, pp. 179-215
-
-
Carlson, E.R.1
Kim, J.2
Mirowski, G.W.3
Stewart, J.C.B.4
Zarbo, R.J.5
-
3
-
-
67649494469
-
Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2
-
Phuchareon J, Ohta Y, Woo JM, Eisele DW, and Tetsu O (2009). Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2. PLoS One 4, e6040.
-
(2009)
PLoS One
, vol.4
, pp. 6040
-
-
Phuchareon, J.1
Ohta, Y.2
Woo, J.M.3
Eisele, D.W.4
Tetsu, O.5
-
4
-
-
33847324517
-
Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: What is the role of elective neck irradiation?
-
Chen AM, Garcia J, Lee NY, Bucci MK, and Eisele DW (2007). Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: what is the role of elective neck irradiation? Int J Radiat Oncol Biol Phys 67, 988-994.
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.67
, pp. 988-994
-
-
Chen, A.M.1
Garcia, J.2
Lee, N.Y.3
Bucci, M.K.4
Eisele, D.W.5
-
5
-
-
33748181930
-
Systemic therapy in the palliative management of advanced salivary gland cancers
-
Laurie SA and Licitra L (2006). Systemic therapy in the palliative management of advanced salivary gland cancers. J Clin Oncol 24, 2673-2678.
-
(2006)
J Clin Oncol
, vol.24
, pp. 2673-2678
-
-
Laurie, S.A.1
Licitra, L.2
-
6
-
-
0034213931
-
RTK mutations and human syndromes when good receptors turn bad
-
Robertson SC, Tynan JA, and Donoghue DJ (2000). RTK mutations and human syndromes when good receptors turn bad. Trends Genet 16, 265-271.
-
(2000)
Trends Genet
, vol.16
, pp. 265-271
-
-
Robertson, S.C.1
Tynan, J.A.2
Donoghue, D.J.3
-
7
-
-
2742529418
-
Human proto-oncogene c-Kit: A new cell surface receptor tyrosine kinase for an unidentified ligand
-
Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, and Ullrich A (1987). Human proto-oncogene c-Kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6, 3341-3351.
-
(1987)
EMBO J
, vol.6
, pp. 3341-3351
-
-
Yarden, Y.1
Kuang, W.J.2
Yang-Feng, T.3
Coussens, L.4
Munemitsu, S.5
Dull, T.J.6
Chen, E.7
Schlessinger, J.8
Francke, U.9
Ullrich, A.10
-
8
-
-
0025065459
-
Primary structure and functional expression of rat and human stem cell factor DNAs
-
Martin FH, Suggs SV, Langley KE, Lu HS, Ting J, Okino KH, Morris CF, McNiece IK, Jacobsen FW, Mendiaz EA, et al. (1990). Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 63, 203-211.
-
(1990)
Cell
, vol.63
, pp. 203-211
-
-
Martin, F.H.1
Suggs, S.V.2
Langley, K.E.3
Lu, H.S.4
Ting, J.5
Okino, K.H.6
Morris, C.F.7
McNiece, I.K.8
Jacobsen, F.W.9
Mendiaz, E.A.10
-
9
-
-
0022626874
-
A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family
-
Besmer P, Murphy JE, George PC, Qiu FH, Bergold PJ, Lederman L, Snyder HW Jr, Brodeur D, Zuckerman EE, and Hardy WD (1986). A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 320, 415-421.
-
(1986)
Nature
, vol.320
, pp. 415-421
-
-
Besmer, P.1
Murphy, J.E.2
George, P.C.3
Qiu, F.H.4
Bergold, P.J.5
Lederman, L.6
Snyder Jr, H.W.7
Brodeur, D.8
Zuckerman, E.E.9
Hardy, W.D.10
-
10
-
-
0030999238
-
Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-Kit, phosphatidylinositol 3-kinase, and p120 (CBL)
-
Sattler M, Salgia R, Shrikhande G, Verma S, Pisick E, Prasad KV, and Griffin JD (1997). Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-Kit, phosphatidylinositol 3-kinase, and p120 (CBL). J Biol Chem 272, 10248-10253.
-
(1997)
J Biol Chem
, vol.272
, pp. 10248-10253
-
-
Sattler, M.1
Salgia, R.2
Shrikhande, G.3
Verma, S.4
Pisick, E.5
Prasad, K.V.6
Griffin, J.D.7
-
11
-
-
0033981729
-
Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertility
-
Blume-Jensen P, Jiang G, Hyman R, Lee KF, O'Gorman S, and Hunter T (2000). Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertility. Nat Genet 24, 157-162.
-
(2000)
Nat Genet
, vol.24
, pp. 157-162
-
-
Blume-Jensen, P.1
Jiang, G.2
Hyman, R.3
Lee, K.F.4
O'Gorman, S.5
Hunter, T.6
-
12
-
-
0033619142
-
Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-Kit mediated activation of the Ras/MAP kinase pathway and c-fos induction
-
Lennartsson J, Blume-Jensen P, Hermanson M, Pontén E, Carlberg M, and Rönnstrand L (1999). Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-Kit mediated activation of the Ras/MAP kinase pathway and c-fos induction. Oncogene 18, 5546-5553.
-
(1999)
Oncogene
, vol.18
, pp. 5546-5553
-
-
Lennartsson, J.1
Blume-Jensen, P.2
Hermanson, M.3
Pontén, E.4
Carlberg, M.5
Rönnstrand, L.6
-
13
-
-
38349094750
-
Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and Raf inhibition: Implications for therapeutic options
-
Senawong T, Phuchareon J, Ohara O, McCormick F, Rauen KA, and Tetsu O (2008). Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and Raf inhibition: implications for therapeutic options. Hum Mol Genet 17, 419-430.
-
(2008)
Hum Mol Genet
, vol.17
, pp. 419-430
-
-
Senawong, T.1
Phuchareon, J.2
Ohara, O.3
McCormick, F.4
Rauen, K.A.5
Tetsu, O.6
-
14
-
-
33746434378
-
Cancer targets in the RAS pathway
-
Rodriguez-Viciana P, Tetsu O, Oda K, Okada J, Rauen K, and McCormick F (2005). Cancer targets in the RAS pathway. Cold Spring Harb Symp Quant Biol 70, 461-467.
-
(2005)
Cold Spring Harb Symp Quant Biol
, vol.70
, pp. 461-467
-
-
Rodriguez-Viciana, P.1
Tetsu, O.2
Oda, K.3
Okada, J.4
Rauen, K.5
McCormick, F.6
-
15
-
-
0032873349
-
KIT protein expression and analysis of c-Kit gene mutation in adenoid cystic carcinoma
-
Holst VA, Marshall CE, Moskaluk CA, and Frierson HF Jr (1999). KIT protein expression and analysis of c-Kit gene mutation in adenoid cystic carcinoma. Mod Pathol 12, 956-960.
-
(1999)
Mod Pathol
, vol.12
, pp. 956-960
-
-
Holst, V.A.1
Marshall, C.E.2
Moskaluk, C.A.3
Frierson Jr, H.F.4
-
16
-
-
0346992281
-
Expression of KIT (CD117) in neoplasms of the head and neck: An ancillary marker for adenoid cystic carcinoma
-
Mino M, Pilch BZ, and Faquin WC (2003). Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma. Mod Pathol 16, 1224-1231.
-
(2003)
Mod Pathol
, vol.16
, pp. 1224-1231
-
-
Mino, M.1
Pilch, B.Z.2
Faquin, W.C.3
-
17
-
-
20044384866
-
Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-Kit: A Princess Margaret Hospital phase II consortium study
-
Hotte SJ, Winquist EW, Lamont E, MacKenzie M, Vokes E, Chen EX, Brown S, Pond GR, Murgo A, and Siu LL (2005). Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-Kit: a Princess Margaret Hospital phase II consortium study. J Clin Oncol 23, 585-590.
-
(2005)
J Clin Oncol
, vol.23
, pp. 585-590
-
-
Hotte, S.J.1
Winquist, E.W.2
Lamont, E.3
Mackenzie, M.4
Vokes, E.5
Chen, E.X.6
Brown, S.7
Pond, G.R.8
Murgo, A.9
Siu, L.L.10
-
18
-
-
23344444802
-
Synergistic effects of imatinib (STI 571) in combination with chemotherapeutic drugs in head and neck cancer
-
Bruce IA, Slevin NJ, Homer JJ, McGown AT, and Ward TH (2005). Synergistic effects of imatinib (STI 571) in combination with chemotherapeutic drugs in head and neck cancer. Anticancer Drugs 16, 719-726.
-
(2005)
Anticancer Drugs
, vol.16
, pp. 719-726
-
-
Bruce, I.A.1
Slevin, N.J.2
Homer, J.J.3
McGown, A.T.4
Ward, T.H.5
-
19
-
-
71849114124
-
The rational treatment of cancer
-
RAWeinberg (Ed). Garland Science, New York, NY
-
Weinberg RA (2007). The rational treatment of cancer. In The Biology of Cancer. RAWeinberg (Ed). Garland Science, New York, NY. pp. 725-796.
-
(2007)
The Biology of Cancer
, pp. 725-796
-
-
Weinberg, R.A.1
-
20
-
-
4344564244
-
Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: Report of two successfully treated cases
-
Alcedo JC, Fabrega JM, Arosemena JR, and Urrutia A (2004). Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: report of two successfully treated cases. Head Neck 26, 829-831.
-
(2004)
Head Neck
, vol.26
, pp. 829-831
-
-
Alcedo, J.C.1
Fabrega, J.M.2
Arosemena, J.R.3
Urrutia, A.4
-
21
-
-
24944587262
-
Imatinib mesylate can induce objective response in progressing, highly expressing KIT adenoid cystic carcinoma of the salivary glands
-
Faivre S, Raymond E, Casiraghi O, Temam S, and Berthaud P (2005). Imatinib mesylate can induce objective response in progressing, highly expressing KIT adenoid cystic carcinoma of the salivary glands. J Clin Oncol 23, 6271-6273.
-
(2005)
J Clin Oncol
, vol.23
, pp. 6271-6273
-
-
Faivre, S.1
Raymond, E.2
Casiraghi, O.3
Temam, S.4
Berthaud, P.5
-
22
-
-
58949089442
-
Hyalinizing clear cell carcinoma: Case series and comprehensive review of the literature
-
Solar AA, Schmidt BL, and Jordan RC (2009). Hyalinizing clear cell carcinoma: case series and comprehensive review of the literature. Cancer 115, 75-83.
-
(2009)
Cancer
, vol.115
, pp. 75-83
-
-
Solar, A.A.1
Schmidt, B.L.2
Jordan, R.C.3
-
23
-
-
0033119801
-
Catenin regulates expression of cyclin D1 in colon carcinoma cells
-
Tetsu O and McCormick F (1999). Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422-426.
-
(1999)
Nature
, vol.398
, pp. 422-426
-
-
Tetsu, O.1
McCormick, F.2
-
24
-
-
77954641921
-
Growth factors, receptors, and cancer
-
RA Weinberg (Ed). Garland Science, New York, NY
-
Weinberg RA (2007). Growth factors, receptors, and cancer. In The Biology of Cancer. RA Weinberg (Ed). Garland Science, New York, NY. pp. 119-158.
-
(2007)
The Biology of Cancer
, pp. 119-158
-
-
Weinberg, R.A.1
-
25
-
-
15644363454
-
Gain-of-function mutations of c-Kit in human gastrointestinal stromal tumors
-
Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, et al. (1998). Gain-of-function mutations of c-Kit in human gastrointestinal stromal tumors. Science 279, 577-580.
-
(1998)
Science
, vol.279
, pp. 577-580
-
-
Hirota, S.1
Isozaki, K.2
Moriyama, Y.3
Hashimoto, K.4
Nishida, T.5
Ishiguro, S.6
Kawano, K.7
Hanada, M.8
Kurata, A.9
Takeda, M.10
-
26
-
-
0036493872
-
The c-Kit mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations
-
Ma Y, Zeng S, Metcalfe DD, Akin C, Dimitrijevic S, Butterfield JH, McMahon G, and Longley BJ (2002). The c-Kit mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 99, 1741-1744.
-
(2002)
Blood
, vol.99
, pp. 1741-1744
-
-
Ma, Y.1
Zeng, S.2
Metcalfe, D.D.3
Akin, C.4
Dimitrijevic, S.5
Butterfield, J.H.6
McMahon, G.7
Longley, B.J.8
-
27
-
-
4444230149
-
Molecular basis of the constitutive activity and STI571 resistance of Asp816Val mutant KIT receptor tyrosine kinase
-
Foster R, Griffith R, Ferrao P, and Ashman L (2004). Molecular basis of the constitutive activity and STI571 resistance of Asp816Val mutant KIT receptor tyrosine kinase. J Mol Graph Model 23, 139-152.
-
(2004)
J Mol Graph Model
, vol.23
, pp. 139-152
-
-
Foster, R.1
Griffith, R.2
Ferrao, P.3
Ashman, L.4
-
28
-
-
33947520803
-
Juxtamembrane-type c-Kit gene mutation found in aggressive systemic mastocytosis induces imatinib-resistant constitutive KIT activation
-
Nakagomi N and Hirota S (2007). Juxtamembrane-type c-Kit gene mutation found in aggressive systemic mastocytosis induces imatinib-resistant constitutive KIT activation. Lab Invest 87, 365-371.
-
(2007)
Lab Invest
, vol.87
, pp. 365-371
-
-
Nakagomi, N.1
Hirota, S.2
-
30
-
-
11144358645
-
High frequency of mutations of the PIK3CA gene in human cancers
-
Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, et al. (2004). High frequency of mutations of the PIK3CA gene in human cancers. Science 304, 554.
-
(2004)
Science
, vol.304
, pp. 554
-
-
Samuels, Y.1
Wang, Z.2
Bardelli, A.3
Silliman, N.4
Ptak, J.5
Szabo, S.6
Yan, H.7
Gazdar, A.8
Powell, S.M.9
Riggins, G.J.10
-
31
-
-
17144436629
-
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
-
Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, et al. (1997). Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15, 356-362.
-
(1997)
Nat Genet
, vol.15
, pp. 356-362
-
-
Steck, P.A.1
Pershouse, M.A.2
Jasser, S.A.3
Yung, W.K.4
Lin, H.5
Ligon, A.H.6
Langford, L.A.7
Baumgard, M.L.8
Hattier, T.9
Davis, T.10
-
32
-
-
0023885845
-
Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins
-
Feig LA and Cooper GM (1988). Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins. Mol Cell Biol 8, 2472-2478.
-
(1988)
Mol Cell Biol
, vol.8
, pp. 2472-2478
-
-
Feig, L.A.1
Cooper, G.M.2
-
33
-
-
0037849951
-
Differences on the inhibitory specificities of H-Ras, K-Ras, and N-Ras (N17) dominant negative mutants are related to their membrane microlocalization
-
Matallanas D, Arozarena I, Berciano MT, Aaronson DS, Pellicer A, Lafarga M, and Crespo P (2003). Differences on the inhibitory specificities of H-Ras, K-Ras, and N-Ras (N17) dominant negative mutants are related to their membrane microlocalization. J Biol Chem 278, 4572-4581.
-
(2003)
J Biol Chem
, vol.278
, pp. 4572-4581
-
-
Matallanas, D.1
Arozarena, I.2
Berciano, M.T.3
Aaronson, D.S.4
Pellicer, A.5
Lafarga, M.6
Crespo, P.7
-
34
-
-
13544251719
-
Mutations in the B-Raf and N-Ras genes in childhood acute lymphoblastic leukaemia
-
Gustafsson B, Angelini S, Sander B, Christensson B, Hemminki K, and Kumar R (2005). Mutations in the B-Raf and N-Ras genes in childhood acute lymphoblastic leukaemia. Leukemia 19, 310-312.
-
(2005)
Leukemia
, vol.19
, pp. 310-312
-
-
Gustafsson, B.1
Angelini, S.2
Sander, B.3
Christensson, B.4
Hemminki, K.5
Kumar, R.6
-
35
-
-
0024292722
-
Most human carcinomas of the exocrine pancreas contain mutant c-K-Ras genes
-
Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, and Perucho M (1988). Most human carcinomas of the exocrine pancreas contain mutant c-K-Ras genes. Cell 53, 549-554.
-
(1988)
Cell
, vol.53
, pp. 549-554
-
-
Almoguera, C.1
Shibata, D.2
Forrester, K.3
Martin, J.4
Arnheim, N.5
Perucho, M.6
-
36
-
-
0023735997
-
KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas
-
Smit VT, Boot AJ, Smits AM, Fleuren GJ, Cornelisse CJ, and Bos JL (1988). KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res 16, 7773-7782.
-
(1988)
Nucleic Acids Res
, vol.16
, pp. 7773-7782
-
-
Smit, V.T.1
Boot, A.J.2
Smits, A.M.3
Fleuren, G.J.4
Cornelisse, C.J.5
Bos, J.L.6
-
37
-
-
18444374405
-
Mutations of the BRAF gene in human cancer
-
Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J,Woffendin H, Garnett MJ, Bottomley W, et al. (2002). Mutations of the BRAF gene in human cancer. Nature 417, 949-954.
-
(2002)
Nature
, vol.417
, pp. 949-954
-
-
Davies, H.1
Bignell, G.R.2
Cox, C.3
Stephens, P.4
Edkins, S.5
Clegg, S.6
-
38
-
-
12144289677
-
Mechanism of activation of the Raf-ERK signaling pathway by oncogenic mutations of B-RAF
-
Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, Jones CM, Marshall CJ, Springer CJ, Barford D, et al. (2004). Mechanism of activation of the Raf-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116, 855-867.
-
(2004)
Cell
, vol.116
, pp. 855-867
-
-
Wan, P.T.1
Garnett, M.J.2
Roe, S.M.3
Lee, S.4
Niculescu-Duvaz, D.5
Good, V.M.6
Jones, C.M.7
Marshall, C.J.8
Springer, C.J.9
Barford, D.10
-
39
-
-
0842303173
-
Reversibility of oncogene-induced cancer
-
Felsher DW (2004). Reversibility of oncogene-induced cancer. Curr Opin Genet Dev 14, 37-42.
-
(2004)
Curr Opin Genet Dev
, vol.14
, pp. 37-42
-
-
Felsher, D.W.1
-
40
-
-
0025940323
-
Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism
-
Giebel LB and Spritz RA (1991). Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci USA 88, 8696-8699.
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 8696-8699
-
-
Giebel, L.B.1
Spritz, R.A.2
-
41
-
-
17344389442
-
Deletion of the SLUG (SNAI2) gene results in human piebaldism
-
Sánchez-Martín M, Pérez-Losada J, Rodríguez-García A, González-Sánchez B, Korf BR, Kuster W, Moss C, Spritz RA, and Sánchez-García I (2003). Deletion of the SLUG (SNAI2) gene results in human piebaldism. Am J Med Genet A 122A, 125-132.
-
(2003)
Am J Med Genet A
, vol.122
, pp. 125-132
-
-
Sánchez-Martín, M.1
Pérez-Losada, J.2
Rodríguez-García, A.3
González-Sánchez, B.4
Korf, B.R.5
Kuster, W.6
Moss, C.7
Spritz, R.A.8
Sánchez-García, I.9
-
42
-
-
0023694835
-
The proto-oncogene c-Kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus
-
Chabot B, Stephenson DA, Chapman VM, Besmer P, and Bernstein A (1988). The proto-oncogene c-Kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335, 88-89.
-
(1988)
Nature
, vol.335
, pp. 88-89
-
-
Chabot, B.1
Stephenson, D.A.2
Chapman, V.M.3
Besmer, P.4
Bernstein, A.5
-
43
-
-
0024280901
-
The dominant-white spotting (W) locus of the mouse encodes the c-Kit proto-oncogene
-
Geissler EN, Ryan MA, and Housman DE (1988). The dominant-white spotting (W) locus of the mouse encodes the c-Kit proto-oncogene. Cell 55, 185-192.
-
(1988)
Cell
, vol.55
, pp. 185-192
-
-
Geissler, E.N.1
Ryan, M.A.2
Housman, D.E.3
-
44
-
-
0031964940
-
Piebaldism with deafness: Molecular evidence for an expanded syndrome
-
Spritz RA and Beighton P (1998). Piebaldism with deafness: molecular evidence for an expanded syndrome. Am J Med Genet 75, 101-103.
-
(1998)
Am J Med Genet
, vol.75
, pp. 101-103
-
-
Spritz, R.A.1
Beighton, P.2
-
45
-
-
0242670019
-
PDGFRA activating mutations in gastrointestinal stromal tumors
-
Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, et al. (2003). PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299, 708-710.
-
(2003)
Science
, vol.299
, pp. 708-710
-
-
Heinrich, M.C.1
Corless, C.L.2
Duensing, A.3
McGreevey, L.4
Chen, C.J.5
Joseph, N.6
Singer, S.7
Griffith, D.J.8
Haley, A.9
Town, A.10
-
46
-
-
0031848146
-
Familial gastrointestinal stromal tumours with germline mutation of the KIT gene
-
Nishida T, Hirota S, Taniguchi M, Hashimoto K, Isozaki K, Nakamura H, Kanakura Y, Tanaka T, Takabayashi A, Matsuda H, et al. (1998). Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet 19, 323-324.
-
(1998)
Nat Genet
, vol.19
, pp. 323-324
-
-
Nishida, T.1
Hirota, S.2
Taniguchi, M.3
Hashimoto, K.4
Isozaki, K.5
Nakamura, H.6
Kanakura, Y.7
Tanaka, T.8
Takabayashi, A.9
Matsuda, H.10
-
47
-
-
0036770178
-
Identification and treatment of chemoresistant inoperable or metastatic GIST: Experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571)
-
Demetri GD (2002). Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571). Eur J Cancer 38(Suppl 5), S52-S59.
-
(2002)
Eur J Cancer
, vol.38
, Issue.SUPPL 5
-
-
Demetri, G.D.1
-
48
-
-
0029822816
-
Involvement of transcription factor encoded by the mi locus in the expression of c-Kit receptor tyrosine kinase in cultured mast cells of mice
-
Tsujimura T, Morii E, Nozaki M, Hashimoto K, Moriyama Y, Takebayashi K, Kondo T, Kanakura Y, and Kitamura Y (1996). Involvement of transcription factor encoded by the mi locus in the expression of c-Kit receptor tyrosine kinase in cultured mast cells of mice. Blood 88, 1225-1233.
-
(1996)
Blood
, vol.88
, pp. 1225-1233
-
-
Tsujimura, T.1
Morii, E.2
Nozaki, M.3
Hashimoto, K.4
Moriyama, Y.5
Takebayashi, K.6
Kondo, T.7
Kanakura, Y.8
Kitamura, Y.9
-
49
-
-
0027204149
-
Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loophelix- zipper protein
-
Hodgkinson CA, Moore KJ, Nakayama A, Steingrímsson E, Copeland NG, Jenkins NA, and Arnheiter H (1993). Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loophelix- zipper protein. Cell 74, 395-404.
-
(1993)
Cell
, vol.74
, pp. 395-404
-
-
Hodgkinson, C.A.1
Moore, K.J.2
Nakayama, A.3
Steingrímsson, E.4
Copeland, N.G.5
Jenkins, N.A.6
Arnheiter, H.7
-
50
-
-
0034142326
-
C-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi
-
Wu M, Hemesath TJ, Takemoto CM, Horstmann MA, Wells AG, Price ER, Fisher DZ, and Fisher DE (2000). C-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev 14, 301-312.
-
(2000)
Genes Dev
, vol.14
, pp. 301-312
-
-
Wu, M.1
Hemesath, T.J.2
Takemoto, C.M.3
Horstmann, M.A.4
Wells, A.G.5
Price, E.R.6
Fisher, D.Z.7
Fisher, D.E.8
-
51
-
-
33746565431
-
Lineage dependency and lineage-survival oncogenes in human cancer
-
Garraway LA and Sellers WR (2006). Lineage dependency and lineage-survival oncogenes in human cancer. Nat Rev Cancer 6, 593-602.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 593-602
-
-
Garraway, L.A.1
Sellers, W.R.2
-
52
-
-
0002608471
-
Growth factor receptors in cell transformation
-
G Peters and KH Vousden (Eds). Oxford University Press, Oxford, UK
-
Carl-Henrik H and Ronnstrand L (1997). Growth factor receptors in cell transformation. In Oncogenes and Tumor Suppressors. G Peters and KH Vousden (Eds). Oxford University Press, Oxford, UK. pp. 55-85.
-
(1997)
Oncogenes and Tumor Suppressors
, pp. 55-85
-
-
Carl-Henrik, H.1
Ronnstrand, L.2
|